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The medium-resolution structure of adenylosuccinate lyase
(PurB) from the bacterial pathogen Staphylococcus aureus in
complex with AMP is presented. Oxalate, which is likely to be
an artifact of crystallization, has been modelled in the active
site and occupies a position close to that where succinate is
observed in orthologous structures. PurB catalyzes reactions
that support the provision of purines and the control of AMP/
fumarate levels. As such, the enzyme is predicted to be
essential for the survival of S. aureus and to be a potential
therapeutic target. Comparisons of this pathogen PurB with
the enzyme from Escherichia coli are presented to allow
discussion concerning the enzyme mechanism. Comparisons
with human PurB suggest that the close similarity of the active
sites would make it difﬁcult to identify species-speciﬁc
inhibitors for this enyme. However, there are differences in
the way that the subunits are assembled into dimers. The
distinct subunit–subunit interfaces may provide a potential
area to target by exploiting the observation that creation of
the enzyme active site is dependent on oligomerization.
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1. Introduction
The purine-biosynthetic pathway is ultimately responsible for
the generation of inosine 50-monophosphate from  -d-ribose-
5-phosphate (Zhang et al., 2008) and provides the essential
purine nucleotides required for DNA replication and cell
division. The pathway consists of ten enzyme-catalyzed steps
in vertebrates (Buchanan & Hartman, 1959) and 11 in
Escherichia coli (Mueller et al., 1994). In this pathway,
adenylosuccinate lyase (PurB; EC 4.3.2.2) catalyzes the
breakdown of 5-aminoimidazole-4-(N-succinylcarboxamide)
ribotide (SAICAR) to 5-aminoimidazole-4-carboxamide
ribotide (AICAR) and fumarate (Fig. 1). PurB demonstrates
dual substrate speciﬁcity and can also break down adenylo-
succinate to adenosine monophosphate (AMP) and fumarate
(Fig. 1); therefore, it also determines the levels of AMP and
fumarate in the cell via the purine-nucleotide cycle. In
humans, mutations in PurB and adenylosuccinate lyase deﬁ-
ciency have profound effects on the central nervous system
(Spiegel et al., 2006). It has been predicted on the basis of
bioinformatics comparisons and metabolic reconstructions
that the purB gene encodes an essential enzyme activity in
Staphylococcus aureus (Heinemann et al., 2005), although we
note that it would be important to genetically and chemically
validate this prediction. Selective inhibition of PurB offers the
possibility of new therapies targeting a range of microbial
infections and structural studies provide useful data to assess
the potential of this protein for such early stage drug discovery
(Hunter, 2009).PurB is classiﬁed along with argino-
succinate lyase, l-aspartase, class II
fumarases and 3-carboxymuconate
lactonase as a member of the aspartase/
fumarase or  -elimination superfamily
of enzymes (Fujii et al., 2003). Crystal
structures of PurB from a number of
organisms have been determined. These
include orthologues from the archaea
Pyrobaculum aerophilum (Toth et al.,
2000) and Thermotoga maritima (Toth
& Yeates, 2000), the eukaryotes
Caenorhabditis elegans (PDB code 1yis;
J. Symersky et al., unpublished work),
Homo sapiens (PDB code 2vd6;
P. Stenmark et al., unpublished work)
and Plasmodium vivax (PDB code 2qga;
Vedadi et al., 2007) and the bacteria
E. coli (Tsai et al., 2007), Bacillus
anthracis (PDB code 2pfm; V. M.
Levdikov, E. V. Blagova, A. J. Wilkinson
& K. S. Wilson, unpublished work),
B. subtilis (Toth et al., 2000) and
Legionella pneumophila (PDB code
3bhg; C. Chang, H. Li, L. Freeman &
A. Joachimiak, unpublished work).
We describe the construction of an
efﬁcient bacterial recombinant expression system, enzyme
puriﬁcation and crystallization protocols and report the crystal
structure of PurB from S. aureus (SaPurB) at 2.5 A ˚ resolution.
Our structure contains one of the reaction products, AMP,
bound in the active site and a nearby strong feature of electron
density has been modelled and successfully reﬁned as oxalate.
Comparisons with previously determined PurB structures are
presented, concentrating on active-site ligand interactions and
the mode of dimerization.
2. Methods
2.1. Cloning and sample preparation
The S. aureus purB gene was ampliﬁed from genomic DNA
(American Type Culture Collection strain 35556, Laboratory
of the Government Chemist Standards Ofﬁce, UK) using the
primers 50-catatgATTGAACGCTATTCTCGAG and 50-ctc-
gagTTATGCTAATCCAGCGCG (the lower-case sequences
correspond to the NdeI/XhoI restriction sites used for
cloning). Following TOPO cloning (Invitrogen) of the PCR
product, the gene was ligated into a pET15b (Novagen)
expression vector modiﬁed to encode a tobacco etch virus
(TEV) protease cleavage site in place of the thrombin
protease cleavage site. This vector was transformed into E. coli
BL21 (DE3) pLysS (Stratagene). Cultures were grown at
room temperature in Luria–Bertani medium supplemented
with 50 mg ml
 1 ampicillin and 12 mg ml
 1 chloramphenicol
overnight, with 0.5 mM isopropyl  -d-1-thiogalactopyranoside
added to induce gene expression, and the cells were harvested
by centrifugation (3000g at 277 K for 30 min). The pellet was
resuspended in 50 mM Tris–HCl pH 7.5, 250 mM NaCl,
20 mM imidazole and the cells were lysed using a French press.
Cell debris was removed by centrifugation (40 000g at 277 K
for 30 min).
SaPurB was puriﬁed with a protocol commonly used in our
laboratory (Dawson et al., 2008). In summary, the ﬁrst stage
involved nickel-afﬁnity chromatography on a 5 ml HisTrap
column (GE Healthcare). A linear concentration gradient was
applied to elute the product, which was dialyzed against
50 mM Tris–HCl, 250 mM NaCl; the His tag was then removed
by incubation overnight with His-tagged TEV protease. The
resulting mixture was applied onto the HisTrap column, which
bound the cleaved His tag, the TEV protease and uncleaved
SaPurB. The SaPurB from which the His tag had been cleaved
was present in the ﬂowthrough. Fractions were analyzed using
SDS–PAGE and those containing SaPurB were pooled. The
protein was further puriﬁed by size-exclusion chromatography
using a Superdex 200 26/60 column (GE Healthcare) equili-
brated with 50 mM Tris–HCl, 250 mM NaCl pH 7.5. This
column had previously been calibrated with molecular-
weight standards: blue dextran (>2000 kDa), thyroglobulin
(669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin
(75 kDa), ovalbumin (43 kDa), carbonic anhydrase
(29.5 kDa), ribonuclease A (13.7 kDa) and aprotinin
(6.5 kDa) (GE Healthcare; data not shown). The high level of
SaPurB purity was conﬁrmed by SDS–PAGE and matrix-
assisted laser desorption/ionization–time-of-ﬂight mass spec-
trometry. The sample was dialyzed into 20 mM Tris–HCl pH
7.5, 50 mM NaCl and concentrated using a Vivaspin 20
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Figure 1
PurB catalyzes two reactions: the conversion of SAICAR to AICAR (a) and the conversion of
adenylosuccinate to AMP (b). In each case fumarate is also produced.(Sartorius) to provide a stock solution for crystallization. A
theoretical extinction coefﬁcient of 59 485 M
 1 cm
 1 at
280 nm was used to estimate the protein concentration
(PROTPARAM; Gasteiger et al., 2005); the theoretical mass
of one subunit was estimated as 49.6 kDa.
SaPurB was crystallized at 293 K by the hanging-drop
vapour-diffusion method using 1 ml protein solution at a
concentration of 11 mg ml
 1 containing 25 mM AMP mixed
with 1 ml reservoir consisting of 45% polyethylene glycol
(PEG) 200, 0.2 M NaCl and 0.1 M sodium phosphate buffer
pH 6.2. Orthorhombic blocks with minimum dimensions of
0.2 mm grew over 2–3 weeks. Crystals were ﬁrst characterized
in-house using a Rigaku MicroMax-007 rotating-anode X-ray
generator coupled to an R-AXIS IV
++ image-plate detector.
The amount of PEG 200 in the mother liquor allowed crystals
to be mounted directly from the drop without additional
cryoprotection. Autoindexing revealed that the crystals were
orthorhombic, with unit-cell lengths that were subsequently
determined as a = 81.6, b= 121.3, c= 105.7 A ˚ . Suitable crystals
were stored in liquid N2 for use in data collection at the
Diamond Light Source (Rutherford Appleton Laboratories,
England).
2.2. X-ray data collection, processing, structure solution and
refinement
Diffraction data were measured on beamline I04 of the
Diamond Light Source using an ADSC Q315 CCD detector.
Data were indexed and integrated using MOSFLM (Leslie,
2006) and scaled using SCALA (Evans, 2006); statistics are
summarized in Table 1. The structure was solved by molecular
replacement using the structure of adenylosuccinate lyase
from T. maritima (PDB code 1c3c; Toth & Yeates, 2000) as the
search model. This model shares approximately 50% sequence
identity to SaPurB. One molecule was located per asymmetric
unit, giving a Z score of 21.1 using the program Phaser
(McCoy et al., 2007). Reﬁnement was performed in
REFMAC5 (Murshudov et al., 1999) utilizing translation/
libration/screw reﬁnement and alternated with inspection of
Fourier syntheses (2Fo   Fc and Fo   Fc) and model manip-
ulation together with ligand incorporation using Coot (Emsley
& Cowtan, 2004). MolProbity (Chen et al., 2010) was used to
investigate model geometry in combination with the valida-
tion tools provided in Coot. Crystallographic statistics are
presented in Table 1. Analyses of surface areas and inter-
actions were made using the PISA service (Krissinel &
Henrick, 2007) and ﬁgures were prepared with PyMOL
(DeLano, 2002). Amino-acid sequence alignments were
carried out using the program MUSCLE (Edgar, 2004). The
coordinates and structure-factor data have been deposited in
the Protein Data Bank with accession code 2x75.
3. Results and discussion
3.1. General comments
SaPurB crystallizes in an orthorhombic system and the
systematic absences indicated either space group I222 or
I212121. Both space groups have eight asymmetric units per
unit cell and a single polypeptide chain, labelled chain A,
constitutes the asymmetric unit, with an estimated solvent
content of 60%. The space-group assignment of I222 was
conﬁrmed using default settings in the program Phaser
(McCoy et al., 2007) and the structure was solved by molecular
replacement and reﬁned to a resolution of 2.50 A ˚ . The log-
likelihood gain score in I222 was 742, compared with a score of
86 in I212121. As will be described, SaPurB forms a tetramer in
the crystal structure and this rulesout space group I212121.T h e
crystallographic statistics and model geometry (Table 1)
indicate that the analysis has produced an acceptable medium-
resolution model. Continuous and well deﬁned electron
density was observed for the entire polypeptide except for
residues 401 and 402. AMP, a product of the catalyzed reac-
tion, was present in the crystallization conditions and well
deﬁned electron density for the ligand was observed in the
active site (data not shown). Electron density compatible with
PEG was located near the C-terminal segment of  7 and the
C-terminal segment of  5 from a symmetry-related subunit
(symmetry operation  x + 1/2,  y + 1/2,  z + 1/2, data not
shown). In addition, a strong electron-density feature
appeared in the active site which we could not explain on the
basis of the known chemical components of the crystallization
mixture. Different molecules were considered and reﬁnements
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Table 1
Crystallographic statistics.
Values in parentheses are for the highest resolution shell.
Space group I222
Unit-cell parameters (A ˚ ) a = 81.6, b = 121.3, c = 105.7
Resolution range (A ˚ ) 97–2.5 (2.64–2.5)
No. of unique reﬂections 17795
Completeness 96.9 (98.7)
Redundancy 5.3 (5.3)
Wilson B factor (A ˚ 2) 56.8
hI/ (I)i 14.3 (2.6)
Rmerge† 4.7 (49.2)
No. of protein residues 428
No. of water molecules 70
No. of AMP molecules 1
No. of oxalate molecules 1
No. of chloride ions 1
Rwork‡/Rfree§ (%) 21.7/28.4
R.m.s.d. from ideal values
Bond lengths (A ˚ ) 0.010
Angles ( ) 1.160
Average B factors (A ˚ 2)
Overall 68.6
Side chain 69.1
Main chain 68.0
AMP 59.9
Oxalate 73.6
PEG 61.4
Chloride 61.0
Ramachandran plot analysis
Favourable 383 [92.5%]
Additionally allowed 7 [6.5%]
Outliers 4 [1%]
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
the ith measurement of reﬂection hkl and hI(hkl)i is the mean value of Ii(hkl) for all i
measurements. ‡ Rwork =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fobs is the observed
structure-factor amplitude and Fcalc is the structure-factor amplitude calculated from the
model. § Rfree is the same as Rwork except calculated with a subset (5%) of data that
were excluded from reﬁnement calculations.attempted. Our tentative interpretation is that this density
represents oxalate (Fig. 2), possibly acquired as a contaminant
of the PEG 200 used in crystallization. Contamination of PEG
and its inﬂuence on protein crystallization has been observed
previously (Jurnak, 1986). In our case, since ethylene glycol is
a precursor of PEG and like PEG itself is susceptible to
contamination with aldehydes and peroxides (Ray & Puva-
thingal, 1985), then breakdown of PEG 200 and/or the
presence of ethylene glycol and subsequent oxidation may
have produced oxalate.
3.2. Structure overview
The SaPurB subunit can be divided into three domains that
combine to form an elongated structure. Domains I and III are
placed at either end of the long helical bundle formed by
domain II (Fig. 3). Domain I comprises residues 1–93, which
form six helices ( 1– 6). Domain II, consisting of residues 94–
349, forms an elongated helical bundle assembled by  7
through  15 as well as a short two-stranded antiparallel
 -sheet ( 1,  2) positioned between  7 and  8. Domain III
comprises ﬁve helices ( 16– 20) constructed from residues
350–431. This domain carries the only unresolved portion of
the structure: residues 401 and 402 that are on a loop linking
 18 with  19 are disordered.
Gel ﬁltration indicates that SaPurB exists as a single species
with an approximate mass of 85 kDa in solution, suggesting
the presence of a dimer under the conditions used during the
ﬁnal stage of puriﬁcation. In the crystal structure, a symmetry-
related subunit (B) related by the crystallographic twofold
axis along unit-cell edge a is the likely
partner for such a dimeric species. The A–B
interface covers an area of approximately
3380 A ˚ 2; almost 16% of the total surface
area of the subunit. As observed in ortho-
logues, the crystal structure reveals the
formation of a tetramer (Fig. 3), which in the
case of SaPurB involves rotation of the A–B
pair about the crystallographic axis along
unit-cell edge b to provide the partner pair
of subunits, which are labelled C and D.T h e
A–C interface extends for approximately
1750 A ˚ 2 or 8% of the surface area of a
subunit, whilst the smallest interface, that
formed between subunits A and D, covers
an area of about 1600 A ˚ 2 or 7.5% of the
subunit surface area. Changes in the multi-
meric state of PurB orthologues have been
reported elsewhere. The B. subtilis enzyme
has been shown to exist largely as a dimeric
species when the protein concentration is
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Figure 3
Ribbon diagrams of the SaPurB subunit, the dimer and the tetramer. (a) A subunit is depicted and coloured from the N-terminus (blue) to the
C-terminus (red). Residues of the subunit interact with three AMP molecules, which are shown in CPK format (C, black; O, red; P, orange). (b)T h e
dimer is formed from two subunits in an antiparallel arrangement. Subunit A is coloured yellow and subunit B is coloured orange. The dimer forms part
of four active sites,which are marked by AMP.(c) The active enzyme SaPurB is a tetramer.Subunit C is coloured green and subunit D iscoloured purple.
Figure 2
Stereoview of the OMIT map of oxalate and interactions in the active site. The OMIT Fo   Fc
difference density map is shown as green chicken wire and contoured at 3 . The protein main
chain is shown in ribbon format coloured according to subunit: yellow, subunit A; orange,
subunit B; purple, subunit D. Side chains are shown as sticks coloured red for O atoms, blue for
N atoms, orange for P atoms and according to subunit as before for C atoms. The oxalate and
AMP C positions are shown in black. Water molecules are depicted as cyan spheres. Dashed
lines represent potential hydrogen-bonding interactions.low ( 0.1 mg ml
 1); however, as the protein concentration
increases the tetrameric species becomes the most abundant
form (Palenchar & Colman, 2003).
3.3. The active site, interactions with ligands and enzyme
mechanism
The tetramer contains four active sites, each formed by
regions donated from three different subunits. In the following
description, A, B or C after the residue numbers serves to
identify which subunit they belong to. We consider distances
between functional groups involved in hydrogen-bonding
interactions to fall within the range 2.5–3.5 A ˚ .
A sequence alignment of PurB proteins for which structures
have been determined was carried out and a subset is
presented in Fig. 4 together with the secondary structure of
SaPurB. The PurB sequences of T. maritima and B. anthracis
share 52 and 70% identity, respectively, to that of SaPurB. The
remainder, L. pneumophila, E. coli, Pl. vivax, C. elegans and
Py. aerophilum, fall within a range from 20 to 33% identity. A
high level of conservation in and around the ligand-binding/
active site is noted, with all of the residues implicated in the
enzyme mechanism being strictly conserved (Fig. 4).
The structure of AMP in the active site of SaPurB (Fig. 5) is
similar to that in the E. coli PurB–AMP complex (Tsai et al.,
2007; PDB code 2ptq). The AMP phosphate accepts hydrogen
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Figure 4
Primary and secondary structure of SaPurB together with sequence alignment of selected PurB sequences. Dark blue stars indicate residues that interact
with ligands in the active site; a dark blue circle identiﬁes a threonine previously thought to be important for activity and discussed in the text. Light blue
stars mark residues that help to position important side chains; light blue diamonds indicate structurally important residues. The orange boxes highlight
disordered regions that correspond to the mobile active-site loop in SaPurB.bonds from Arg4C, Tyr5C, Asn276C, Ser306A, Arg310A and
via a water-mediated association with Arg326A. The ribose
O20 donates a hydrogen bond to the Arg67A carbonyl and O30
accepts hydrogen bonds from the amide of Asp69A and
Arg4C NH2. The glycosidic O40 is 3.2 A ˚ from Asp69A OD1,
suggesting that the latter is protonated (data not shown). The
adenine N1 accepts a hydrogen bond from Thr95A OG1; N6
donates hydrogen bonds to His141B NE2 and Gln212A OE1,
residues which are themselves positioned by hydrogen-
bonding interactions.The loop Gly182-Ala183-Val184-Gly185,
which is conserved in PurB sequences (Fig. 4), is positioned
such that the main-chain carbonyl of Ala183 can accept a
hydrogen bond from Gln212A NE2. His141 in SaPurB
corresponds to His171 in E. coli PurB and is the catalytic acid
for the mechanism (Tsai et al., 2007; Kozlov et al., 2009).
The oxalate binds accepting hydrogen bonds donated from
Ser94A OG and Gln259A NE2 and a water molecule that in
turn interacts with the side chain of Thr95 (Fig. 2). The
distance between an oxalate oxygen and Ser94 OG is 3.6 A ˚
and this may indicate a hydrogen bond. In contrast, the
oxalate is 3.4 A ˚ distant from adenine N6 but the geometry is
not optimal for hydrogen-bond formation (Leonard et al.,
1995). The oxalate occupies a position similar to that observed
for fumarate in the active site of human PurB (PDB code
2vd6) and to that of the succinate moiety observed in the
E. coli PurB–adenylosuccinate complex (PDB code 2ptr).
A model of SaPurB with adenylosuccinate was produced
(Fig.6) using the human PurB complex to aid the analysis. Two
threonines, Thr93 and Thr140 in SaPurB, are proposed to bind
the succinyl moiety (Segall et al., 2007). In SaPurB, Thr93 is
almost 8 A ˚ distant from N6. There is a water-mediated link
between Thr140 and Asn270 and the asparagine is the more
likely residue to interact with the succinyl group. Gln212 is
placed to interact with AMP N6 and a carbonyl on the
modelled SAICAR–adenylosuccinate. In SaPurB, Gln259
binds the oxalate, is positioned on a loop that displays
elevated thermal parameters (data not
shown) and could undergo a small confor-
mational change to interact with substrate/
products.
Two conserved residues, Ser94 and Ser306
in SaPurB (Figs. 4 and 5), have previously
attracted attention (Segall et al., 2007).
Ser94 is close to His68 and might inﬂuence
the pK to favour the protonated form. In
SaPurB His68 ND1 accepts a hydrogen
bond from the Val70 amide and thus NE2
would under normal conditions carry a
proton. Our model suggests that Ser94, like
Ser306, binds substrate. In SaPurB Asp69
orients Arg310 so that it can in turn bind the
substrate phosphate.
One side of the SaPurB active site is
formed by a mobile loop that links  5 and
 12. The electron density for this loop is
more diffuse than in other parts of the
structure and the thermal parameters are
higher (data not shown). In most other PurB
structures this loop is completely disordered
(Fig. 4). In E. coli PurB this loop is disor-
dered in the apo structure but ligand binding
induces a reorganization of the loop to close
the ligand-binding site (Tsai et al., 2007).
PurB catalyzes a  -elimination that is
thought to occur via a general acid–base
uni–bi mechanism (Bridger & Cohen, 1968;
Casey & Lowenstein, 1987). Previous
studies identiﬁed His141, His68 and Ser262
as important residues (Lee et al., 1997, 1998,
1999; Tsai et al., 2007). The conserved
Ser262 of SaPurB is positioned on the
mobile loop near the active site and may
abstract the C
  proton of the substrate,
helping to create a carbanion intermediate.
His171 is the likely proton donor to N6 to
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Figure 6
Stereoview of the adenylosuccinate model in the active site of SaPurB. The colour scheme is
the same as that used in Fig. 2, except that the C atoms of the ligand are shown in light blue.
Figure 5
Stereoview of the active site. A molecule of AMP is bound in the active site formed by regions
of three of the four subunits. There are four active sites per tetramer, with each active site
formed by contributions from three of the four subunits, in this case by A (yellow), B (orange)
and D (purple). The same colour scheme is used as in Fig. 2.support breakage of the C—N bond. The placement of the
adenine in the SaPurB active site with respect to His141
suggests it is unlikely that protonation of N1 occurs during
catalysis, which was a possibility presented by Tsai et al.
(2007).
His141 has been suggested to be the catalytic base (Lee et
al., 1997), forming a charge-relay pair with Glu275 to extract a
proton from the substrate (Toth & Yeates, 2000) or alter-
natively Ser262 (Tsai et al., 2007; corresponding to Ser295
in E. coli). The latter assignment was made from structural
information on the apo form of E. coli PurB, in which the side
chain of His171 (His141 in SaPurB) was rotated away from the
position expected for it to play a role in catalysis. In E. coli
PurB structures the highly conserved Ser295 (Ser262 of
SaPurB) is close to the site of catalysis. This is not the situation
in SaPurB, where the conformation of the active-site loop
holds Ser262 distant from the catalytic site (Fig. 7). Lys268 of
SaPurB, a strictly conserved residue (Fig. 4), is positioned with
its NZ atom 2.8 A ˚ from a succinyl carbonyl. Mutagenesis of
the equivalent lysine in B. subtilis PurB decreased the enzyme
activity signiﬁcantly (Brosius & Colman, 2002).
Our model supports the idea that His9 of the E. coli
enzyme, which is equivalent to SaPurB His68, is not the
catalytic base but rather binds and orients the substrate to
interact with fumarate (Tsai et al., 2007). In SaPurB the
oxalate is 3.8 A ˚ distant from His68, but our model (Fig. 6)
suggests that the distance would be
about 3 A ˚ in the substrate complex.
3.4. Dimer interface and the potential
for inhibitor development
We were intrigued by two observa-
tions. Firstly, a tetramer (or dimer of
dimers) is required to produce a func-
tional enzyme since three subunits are
required to contribute residues to form
an active site. Secondly, there is less
sequence conservation amongst the
PurB residues involved in the
assembly of the quaternary structure
than those around the active sites.
We decided to consider the dimer
interface as a potential target for
screening and structure-based drug-
discovery methods.
Targeting transient protein–protein
interactions or the interface of oligo-
meric assemblies by screening and
structure-based methods to ﬁnd small-
molecule drug-like inhibitors presents a
signiﬁcant challenge (Yin & Hamilton,
2005). Complicating factors include the
high degree of speciﬁcity and the large
areas of interactions involved in
complex formation. Nevertheless, PurB
exists in dimeric and tetrameric forms,
with enzyme activity restricted to the
tetrameric form. Therefore, preventing
the formation of or destabilizing the
tetramer provides a route to enzyme
inhibition. Our interest was furthered
by the observation that there is a
marked reduction in sequence conser-
vation amongst those residues involved
in the assembly of the quaternary
structure.
In support of such an approach, we
note that in excess of 30 point mutations
have been identiﬁed that cause human
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Figure 7
Stereoview of the different conformations displayed by the active-site loop. The SaPurB structure is
shown in purple and the E. coli enzyme structure is shown in pink. The adenylosuccinate is depicted
as in Fig. 6.
Figure 8
The dimer–dimer interface of (a) the human enzyme and (b) SaPurB. The protein is depicted as a
van der Waals surface coloured blue for basic properties, red for acidic and grey for neutral. For
reference, the position of  12 in SaPurB is marked.adenylosuccinate lyase deﬁciency, several of which inﬂuence
the stability of the tetramer (Spiegel et al., 2006). For example,
the mutation of Lys246 to glutamic acid in the human enzyme
is located at the A–B or C–D subunit interface and results in a
predominantly monomeric protein with negligible enzyme
activity. In addition, the presence of an Arg194-to-cysteine
mutation has been demonstrated to reduce the thermal
stability of the B. subtilis enzyme tetramer, leading to signiﬁ-
cant impairment of catalytic activity (Ariyananda et al., 2009).
Visualization of the electrostatic properties of the dimer–
dimer interface involved in tetramer formation for both the
human and S. aureus enzymes was achieved using the Adap-
tive Poisson-Boltzman Solver (Baker et al., 2001; Fig. 8). In
SaPurB two acidic pockets are formed  13 A ˚ from either end
of the helical coil region formed by domain II of each
monomer within the A–B dimer. The identical view of the
human enzyme reveals a less acidic and smaller pocket. The
residues forming the surface of this pocket are contributed
from  10,  12 and from the loop linking  12 to  13. The
symmetry of the dimer leads to a second pocket being formed
15 A ˚ away and when the symmetry of the tetramer is
considered four such pockets are created which combine to
form two cavities within the core of the tetramer of approxi-
mately 13   10   10 A ˚ in size. As mentioned perviously,
targeting interface regions to disrupt oligomerization presents
a signiﬁcant challenge to drug discovery but this region in
SaPurB may be more attractive owing to the symmetry of the
tetramer. The effect of a small molecule targeted to the pocket
on the surface of one subunit could be ampliﬁed by the
proximity of four such pockets, offering the potential to
exploit multivalent ligands.
4. Conclusions
The SaPurB structure displays a conserved fold and mode of
oligomerization compared with orthologous enzymes. The
active sites are highly conserved between species and this
extends to the presence of a ﬂexible loop at the active site. The
SaPurB structure contained AMP and a likely contaminant,
oxalate, in the active site. The high degree of conservation in
the PurB active sites would render it difﬁcult to identify a
potent species-speciﬁc inhibitor of value in the development
of new therapeutic agents. In contrast, the dimer interface of
PurB from S. aureus appears to be sufﬁciently distinct from
that observed for the human orthologue that it may represent
a potential target for which inhibitors might be developed.
However, we note the not inconsiderable difﬁculties in
adopting such an approach.
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